Image For Activity Cover
NSF February 2021: Gene and viral therapy for GBM Volume 50, issue 2
Course Overview

Neurosurgical Focus covers a different topic in-depth each month. Enhanced by color images and video clips, each peer-reviewed issue constitutes a state-of-the-art “textbook chapter” in the field of neurosurgery. 

While Neurosurgical Focus is open-access and has been free to the public since 1996, claiming CME credit is free only for AANS members. Each monthly issue offers 3 credits - earn up to 36 CME annually.

CME Credit
Earn up to 3 CME credits by participating.
Learning Objectives

Upon completion of this CME activity, participants should be able to:

  1. The participant will develop a better understanding of the potential role of gene and viral therapies for glioblastoma treatment.
  2. The participant will develop a greater knowledge of targets for gene therapy and viral vectors used for glioblastoma treatment.
  3. The participant will learn about the methods for gene and viral therapy delivery.
  4. The participant will gain a greater understanding and appreciation of the clinical trial designs and safety issues around gene and viral therapy in neurosurgical neuro-oncology.
Summary
Availability: On-Demand
Cost: Member: $0.00
Non-Member: $79.00
Resident: $0.00
Credit Offered:
3 CME Credits
Powered By